Rani Therapeutics Faces Delisting Notice
Ticker: RANI · Form: 8-K · Filed: May 6, 2025 · CIK: 1856725
| Field | Detail |
|---|---|
| Company | Rani Therapeutics Holdings, Inc. (RANI) |
| Form Type | 8-K |
| Filed Date | May 6, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, listing-standards
TL;DR
Rani Therapeutics might get delisted - big trouble brewing.
AI Summary
Rani Therapeutics Holdings, Inc. filed an 8-K on May 6, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, and a transfer of listing. The filing indicates potential issues with the company's continued listing on a stock exchange, though specific details regarding the rule or standard not met are not provided in this excerpt.
Why It Matters
This filing signals potential financial distress or non-compliance with exchange rules, which could significantly impact investor confidence and the company's ability to trade publicly.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's public trading status, indicating severe compliance or financial issues.
Key Players & Entities
- Rani Therapeutics Holdings, Inc. (company) — Registrant
- 001-40672 (company) — Commission File Number
- 2051 Ringwood Avenue, San Jose, California 95131 (company) — Business Address
- May 01, 2025 (date) — Earliest event reported
- May 6, 2025 (date) — Date of Report
FAQ
What specific listing rule or standard has Rani Therapeutics Holdings, Inc. failed to satisfy?
The provided excerpt of the 8-K filing states a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard' but does not specify which rule or standard has been violated.
What is the exact date of the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing is May 01, 2025.
What is the Commission File Number for Rani Therapeutics Holdings, Inc.?
The Commission File Number for Rani Therapeutics Holdings, Inc. is 001-40672.
What is the business address of Rani Therapeutics Holdings, Inc.?
The business address of Rani Therapeutics Holdings, Inc. is 2051 Ringwood Avenue, San Jose, California 95131.
What is the purpose of this Form 8-K filing?
This Form 8-K filing serves as a Current Report, specifically to notify the SEC of a delisting notice or failure to meet listing standards, and a transfer of listing.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Rani Therapeutics Holdings, Inc. (RANI).